Skip to Main Content

Paper Details

Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants.
bioRxiv
23
2021
B, B.1, SARS, SARS-CoV-2, escape mutants
Author NameAffiliation
Lingshu WangVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Tongqing ZhouVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Sandeep NarpalaVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Yaroslav TsybovskyInc., Frederick National Laboratory for Cancer Research
Nicole A Doria-RoseVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Baoshan ZhangVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Ralph S BaricUNC Chapel Hill School of Public Health, University of North Carolina School of Medicine
Ralph S BaricUniversity of North Carolina School of Medicine
Ralph S BaricUNC Chapel Hill School of Public Health, University of North Carolina School of Medicine
Ralph S BaricUniversity of North Carolina School of Medicine
Adrian B McDermottVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Peter D KwongVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
John R MascolaVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • 1 - 13

Datasets